← The Signal Report Work with me

Report 021 · Supplements

What 'clinically proven' really means

Two words show up on a lot of supplement labels: "clinically proven," "scientifically backed." They sound like a verdict. Legally, they carry a specific evidence bar, and the FTC spent 2026 reminding an industry it exists.

Disclosure first, because it matters here: I formulate and sell functional-mushroom supplements. I have a commercial stake in this category, so I write the marketing copy that this whole piece is about holding to account. That is exactly why I want to be precise about where the line sits, because the same rule that governs the companies getting sued governs me.

Here is the thing most shoppers never get told: "clinically proven" and "scientifically backed" are not regulated phrases with a fixed legal definition. You will not find a statute that says a product earns the words after N trials. What is regulated is the evidence a company must already hold before it makes a health claim at all. The words are marketing. The bar behind them is law. And in 2026 the Federal Trade Commission ran a string of cases that show what happens when the words run out ahead of the evidence.

The case that makes the standard concrete

In June 2026 the FTC sued the multilevel marketer Amare Global Holdings and three of its principals, including its founding brand partner and its former chief science officer, over how its supplements were marketed for children and adults. According to the trade and legal coverage, brand partners promoted products like Happy Juice, Kids Mood+, and Kids Happy Juice as "scientifically backed" or "clinically proven" to treat or reduce depression, anxiety, and ADHD, with one product described as clinically proven to lower depression and anxiety scores, and posts that promoted a children's product alongside statistics about youth suicide.

Set aside the specific products for a second, because the mechanics are the evergreen part. The former chief science officer named in the case had already been under a 2005 FTC order that barred him, and anyone acting with him, from making claims about a product's health benefits "without possessing and relying upon competent and reliable scientific evidence that substantiates the representation," and from misrepresenting the results of scientific studies. In June 2026 the FTC went back to court with a contempt motion arguing that order had been violated. Same phrase, twenty-one years apart: competent and reliable scientific evidence. That is the actual standard hiding under "clinically proven."

What "competent and reliable scientific evidence" is

The FTC's own guidance defines the standard as tests, studies, or other evidence "based on the expertise of professionals in the relevant field, conducted and evaluated in an objective manner using procedures generally accepted in the profession." Read plainly, for a health claim on a supplement that typically means well-controlled human clinical trials. Not a rat study. Not a petri dish. Not one company-funded write-up that happened to land the right way. And crucially, the company is supposed to hold that evidence before it makes the claim, not go looking for it after a regulator calls.

So when a label says "clinically proven," the honest translation is a question, not a conclusion: proven by which clinical study? On this product, or on a single ingredient in it? At this dose, or at ten times it? In people like the buyer, or in a different population entirely? A phrase can be technically defensible and still be pointing at something much smaller than it sounds. In an earlier report I walked through a lion's mane study where the marketing-friendly "clinically shown" rested on a single secondary result, a hand-dexterity task, while the two things the study actually set out to measure came back flat. The claim wasn't fabricated. It was just aimed at the pegboard, not the promise.

How to read the claim in the aisle

You do not need a science degree to pressure-test "clinically proven." You need five questions, and honest copy will survive all five:

Was it a human trial? Cells and mice are where hypotheses start, not where claims are earned. "Shown in studies" that turns out to mean a cell assay is a tell.

Was it this product? A trial on pure cordyceps does not back a claim about a six-mushroom blend, and a blend result cannot be pinned on any one ingredient. Watch for the study that quietly swaps the tested formula for the one on sale.

At the dose in the bottle? Effects that only appear at research doses, taken for weeks, tell you nothing about two capsules of a lower-strength consumer version.

In people like you? A result in diagnosed patients is real and also may say nothing about a healthy adult buying it as a daily hedge.

Can you actually find it? A real clinical claim traces to a citation you can open: a journal, a year, a DOI. "Clinically proven" with no paper behind it is a vibe, not evidence.

The signal

The FTC's line, stripped of the legalese, is one a good formulator should be able to say out loud without flinching: you have to hold the evidence before you make the claim, and the evidence has to be the kind a fair skeptic in the field would accept. "Clinically proven" is not a magic phrase that upgrades a hunch. It is a promise that somewhere there is a competent human study on this product, at this dose, in people like the buyer, and that you could hand it over if asked. When a company can't, the words were never doing scientific work. They were doing marketing work in a lab coat. The whole job, the entire reason a publication like this exists, is telling those two apart, on other people's labels and on my own.

Disclosure, again, plainly: I founded and run Shroombiosis (a company I run), which formulates and sells functional-mushroom supplements, so I have a commercial stake in the category I'm writing about holding to a standard. Nothing here is sponsored and no link earns a commission; here's the full policy. And a recommendation with no stake at all: if performance nutrition is your lane (a different category from what I make), Die Tryin Co. is a fellow combat-veteran-owned brand I'm glad to point you to; I don't own it and earn nothing from the link.

Not medical advice. This is educational analysis, not a recommendation. A study is not a prescription. Talk to a qualified clinician before acting on anything you read here. Full disclaimer →

Sources

  1. Federal Trade Commission, "FTC Sues to Stop Amare Global Holdings from Misrepresenting the Health Benefits of Its Dietary Supplements for Children and Adults," June 2026. (Underlying primary. The FTC page returned an access block on fetch, so the case specifics here are cited as reported by the trade and legal coverage below, which I opened and read.)
  2. NutraIngredients-USA, "FTC sues Amare over mental health supplement claims," 4 June 2026. (Opened. Defendants, products, and the "scientifically backed" / "clinically proven" claim language.)
  3. The National Law Review, "FTC Announces Contempt Motion Against Dietary Supplement Provider," June 2026. (Opened. The 2005 order and its verbatim "competent and reliable scientific evidence that substantiates the representation" language; the June 12, 2026 contempt motion.)
  4. Truli, "FTC Health Claims in 2026: What Supplement Brands Need to Know," 2026, summarizing FTC guidance. (Opened. The FTC definition of "competent and reliable scientific evidence," and the human-trial-versus-animal/in-vitro/single-study distinction.)
Onur Oncer
Onur Oncer

U.S. Army combat veteran (Counter-IED / Electronic Warfare), peer-reviewed researcher in microwave spectroscopy, and founder & CEO of Shroombiosis. Consults on laboratory operations, AI, and supplement formulation.

← All reports